Compare CoreWeave (CRWV) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CoreWeave vs Nuvation Bio Inc. Class A Common Stock — how do they compare? CoreWeave trades at $83.38 (market cap $48.78B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: CoreWeave is far larger — about 28.5× Nuvation Bio Inc. Class A Common Stock's market cap, and CoreWeave is more actively traded (19,704,178 versus 5,448,712). Which is the better fit depends on your goals — on Pluang, investors hold CoreWeave for 6 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| CRWV | NUVB | |
|---|---|---|
Market Cap | $48.78B | $1.71B |
Volume | 19,704,178 | 5,448,712 |
Sector | Technology | Health |
52-Week High | $143.08 | $9.54 |
52-Week Low | $60.82 | $3.41 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $94.85B | $1.30B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CoreWeave
CoreWeave provides cloud computing infrastructure designed for AI workloads. Its platform gives organizations access to large-scale GPU computing and cloud services for training and running AI models.
Read more on CRWV →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
